Sign for Notice Everyday    Sign Up| Sign In| Link| English|

Our Sponsors

    Receive Latest News

    Feedburner
    Share Us


    WEBINAR ON SERIOUS ADVERSE EVENTS TO KNOW THE REPO 2016 - What is a Serious Adverse Events and how do I handle these - By Compliance Global Inc

    View: 325

    Website https://complianceglobal.us/product/700423/SarahFowler-Dixon/webinar-on-handling-serious-adverse-eve | Want to Edit it Edit Freely

    Category Online webinar; Education

    Deadline: June 22, 2016 | Date: June 22, 2016

    Venue/Country: Online Training, U.S.A

    Updated: 2016-05-27 18:57:18 (GMT+9)

    Call For Papers - CFP

    Overview:

    Serious adverse events along with their cousins, serious adverse reactions, anticipated events, unanticipated events and unanticipated problems are often confused and misunderstood.

    Why Should You Attend:

    Regulations and guidance can be overwhelming and seem conflicting when it comes to handling serious adverse events.

    Areas Covered in this Webinar:

    This webinar on serious adverse events, will show you why it is important to know when and what needs to be submitted, reviewed, and approved by an Institutional Review Board (IRB) and what can be handled by the investigator as non-reporting of events that are considered reportable can lead to issues related to non-compliance.

    Learning Objectives:

    ICH guidelines and Good Clinical Practice (GCP)

    Department of Health and Human Services (DHHS) guidance

    Food and Drug Administration (FDA) guidance

    Definitions

    Potential effects on consent and the protocol

    Who Will Benefit:

    Human Subjects Research Personnel

    Clinical Research Personnel

    New Clinical Research Coordinators

    New Principal Investigator Positions

    Administration in charge of Clinical Research

    Regulatory Compliance Personnel

    For more information, please visit : https://complianceglobal.us/product/700423/SarahFowler-Dixon/webinar-on-handling-serious-adverse-events/1

    Email: supportatcomplianceglobal.us

    Toll Free: +1-844-746-4244

    Tel: +1-516-900-5515

    Level:

    Intermediate

    Speaker Profile:

    Sarah Fowler-Dixon, PhD, CIP is Education Specialist and instructor with Washington University School of Medicine. She has developed a comprehensive education program for human subject research which has served as a model for other institutions. She crafted budgets, policies, procedures, reporting, and training for the new program.

    She has initiated the planning, development, authorship and implementation of many human subjects’ research policies, practices, guidelines, submission and reviewer forms often working with state and federal authorities. She has provided consultation regarding ethical, federal, state, and institutional requirements for faculty and staff both in the design and execution of their projects and teaches research ethics and regulatory affairs and the fundamentals of research management to graduate and undergraduate students.

    More recently, she led a task force in the development of the Community Engaged Research Program at Washington University. Dr. Fowler-Dixon has simultaneously served as an Independent Consultant, providing expertise and creating supplemental educational materials, including a copyrighted workbook. Prior to joining Washington University, Dr. Fowler-Dixon was the Educational Development and Learning Specialist for Saint Louis University serving on various committees to improve research, procedures, community outreach, and retention.


    Keywords: Accepted papers list. Acceptance Rate. EI Compendex. Engineering Index. ISTP index. ISI index. Impact Factor.
    Disclaimer: ourGlocal is an open academical resource system, which anyone can edit or update. Usually, journal information updated by us, journal managers or others. So the information is old or wrong now. Specially, impact factor is changing every year. Even it was correct when updated, it may have been changed now. So please go to Thomson Reuters to confirm latest value about Journal impact factor.